RYR2 and early-onset autosomal dominant Alzheimer disease: Moreover, as mentioned above, direct injections into the hippocampi of amyloid beta peptide oligomers (AβOs), which are causative agents of Alzheimer’s disease, by engaging oxidation-mediated reversible pathways, increase single RyR2 channel activation by Ca2+ and cause considerable spatial memory deficits.